We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

85 hedge funds and large institutions have $443M invested in Foundation Medicine, Inc. in 2013 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

825% more capital invested

Capital invested by funds: $47.9M → $443M (+$396M)

756% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 9

400% more funds holding

Funds holding: 1785 (+68)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
85
Holders Change
+68
Holders Change %
+400%
% of All Funds
2.47%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
77
Increased
4
Reduced
4
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$2.21M +$2.6M +92,869 New
Principal Financial Group
27
Principal Financial Group
Iowa
$1.93M +$2.26M +80,800 New
NIP
28
Nicholas Investment Partners
California
$1.75M +$2.05M +73,384 New
BA
29
BlackRock Advisors
Delaware
$1.67M +$1.96M +70,264 New
CCM
30
Cupps Capital Management
Illinois
$1.6M +$1.28M +45,965 +218%
GI
31
GLG Inc
New York
$1.59M +$1.86M +66,643 New
FWIA
32
Fort Washington Investment Advisors
Ohio
$1.58M +$1.85M +66,223 New
Vanguard Group
33
Vanguard Group
Pennsylvania
$1.57M +$1.84M +65,940 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.21M +$1.42M +50,873 New
Franklin Resources
35
Franklin Resources
California
$1.08M +$1.27M +45,400 New
Millennium Management
36
Millennium Management
New York
$1.05M +$1.23M +44,136 New
FM
37
Forward Management
California
$991K +$1.35M +48,120 New
TCIM
38
TIAA CREF Investment Management
New York
$957K +$1.12M +40,195 New
HCMT
39
Highland Capital Management (Texas)
Texas
$860K +$1.01M +36,107 New
Geode Capital Management
40
Geode Capital Management
Massachusetts
$787K +$924K +33,050 New
STC
41
SEI Trust Company
Pennsylvania
$769K +$902K +32,284 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$723K +$397K +14,207 +88%
Wells Fargo
43
Wells Fargo
California
$686K +$806K +28,822 New
Citadel Advisors
44
Citadel Advisors
Florida
$651K -$14M -501,033 -95%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$625K +$709K +25,352 New
Primecap Management
46
Primecap Management
California
$619K -$112K -4,000 -13%
Calamos Advisors
47
Calamos Advisors
Illinois
$525K +$616K +22,036 New
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$496K +$581K +20,800 New
BBA
49
Baker Bros. Advisors
New York
$476K +$559K +20,000 New
CBOA
50
Commonwealth Bank of Australia
Australia
$441K +$517K +18,500 New

FMI Hedge Fund Activity: Q4 2013 in Review

85 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q4 2013, worth a combined $443M — up 825% from $47.9M a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new FMI positions and 9 closed out — a net gain of 68 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $54.4M. The largest seller was Citadel Advisors, cutting an estimated $14M.

  • 85 institutional investors held Foundation Medicine, Inc. (FMI) as of Q4 2013, up from 17 in Q3 2013.
  • Funds reported $443M of Foundation Medicine, Inc. stock for Q4 2013, up 825% quarter-over-quarter.
  • 77 funds opened new Foundation Medicine, Inc. positions in Q4 2013 and 9 closed out, a net change of +68 holders.
  • The largest Foundation Medicine, Inc. buyer in Q4 2013 was Gilder Gagnon Howe & Co, an estimated $54.4M added.
  • The largest Foundation Medicine, Inc. seller in Q4 2013 was Citadel Advisors, an estimated $14M sold.

Based on aggregated 13F filings for Q4 2013.